| Homo sapiens |
Haemophilus ducreyi 35000HP |
infected host |
Skin tissue |
6-8 days |
|
|
NP_001304772 |
Q8TAG5 |
VSTM2A |
244 aa |
V-set and transmembrane domain-containing protein 2A isoform 3 precursor |
4.6e-5 |
●●●●○ -3.1 |
-3.10095725888262 |
| Homo sapiens |
Haemophilus ducreyi 35000HP |
infected host |
Skin tissue |
6-8 days |
|
|
NP_001092805 |
Q92561 |
PHYHIP |
330 aa |
phytanoyl-CoA hydroxylase-interacting protein |
6.4e-15 |
●●●●○ -3.1 |
-3.10298657320475 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
pathogen |
Lung tissue |
16 h |
Bacterial control measured at 37ºC |
HKX07_RS03800 |
WP_003093621 |
Q7DC82 |
phzC1 |
405 aa |
3-deoxy-7-phosphoheptulonate synthase |
3.6e-10 |
●●●●○ -3.1 |
-3.10435866975527 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_4061 |
WP_011192667 |
Q669B0 |
nuoL |
614 aa |
NADH-quinone oxidoreductase subunit L |
8.4e-30 |
●●●●○ -3.1 |
-3.10483808950141 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
infected host |
Lymphoid tissue |
3 days |
|
|
NP_001295215 |
O89106 |
Fhit |
150 aa |
bis(5'-adenosyl)-triphosphatase isoform 2 |
1.3e-5 |
●●●●○ -3.11 |
-3.10528687415003 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
infected host |
Lung tissue |
16 h |
|
|
NP_068689 |
Q9R0N9 |
Syt9 |
491 aa |
synaptotagmin-9 |
0.047 |
●●●●○ -3.11 |
-3.10661460917365 |
| Homo sapiens |
Haemophilus ducreyi 35000HP |
infected host |
Skin tissue |
6-8 days |
|
|
NP_006151 |
Q15784 |
NEUROD2 |
382 aa |
neurogenic differentiation factor 2 |
0.00095 |
●●●●○ -3.11 |
-3.10663440144708 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
infected host |
Lymphoid tissue |
3 days |
|
|
NP_001258332 |
P34914 |
Ephx2 |
536 aa |
bifunctional epoxide hydrolase 2 isoform c precursor |
7.2e-29 |
●●●●○ -3.11 |
-3.10727277140354 |
| Homo sapiens |
Haemophilus ducreyi 35000HP |
infected host |
Skin tissue |
6-8 days |
|
|
NP_001193933 |
Q9BY64 |
UGT2B28 |
335 aa |
UDP-glucuronosyltransferase 2B28 isoform 2 precursor |
0.016 |
●●●●○ -3.11 |
-3.10731823523785 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
pathogen |
Lung tissue |
16 h |
Bacterial control measured at 37ºC |
HKX07_RS13695 |
WP_010895606 |
Q9I1H3 |
ambE |
2124 aa |
amino acid adenylation domain-containing protein |
4.3e-170 |
●●●●○ -3.11 |
-3.10765967083655 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
infected host |
Lung tissue |
16 h |
|
|
NP_001013395 |
Q66JY6 |
Arhgef39 |
344 aa |
rho guanine nucleotide exchange factor 39 |
0.0078 |
●●●●○ -3.11 |
-3.10887108695528 |
| Homo sapiens |
Salmonella enterica subsp. enterica serovar Typhimurium str. SL1344 |
pathogen |
Hela-S3 cells |
4 h |
Bacterial control measured at 37ºC |
SL1344_2248 |
WP_000533921 |
A0A0H3NDQ9 |
yfaE |
84 aa |
ferredoxin-like diferric-tyrosyl radical cofactor maintenance protein YfaE |
0.0088 |
●●●●○ -3.11 |
-3.10977688236986 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
pathogen |
Lung tissue |
16 h |
Bacterial control measured at 37ºC |
HKX07_RS18995 |
WP_003114954 |
Q9I476 |
|
314 aa |
4-hydroxyproline epimerase |
6.0e-6 |
●●●●○ -3.11 |
-3.11025721834105 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_3678 |
WP_011192846 |
I3NIC6 |
|
525 aa |
ABC transporter substrate-binding protein |
7.0e-6 |
●●●●○ -3.11 |
-3.11097292657713 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
infected host |
Lung tissue |
16 h |
|
|
NP_938081 |
Q7M6W8 |
Zfp273 |
501 aa |
zinc finger protein 273 |
0.0016 |
●●●●○ -3.11 |
-3.11175963160307 |
| Homo sapiens |
Streptococcus pneumoniae D39 |
host |
Human type II lung epithelial cell line A549 |
30 min |
|
|
NP_008883 |
O75841 |
UPK1B |
260 aa |
uroplakin-1b |
1.1e-17 |
●●●●○ -3.11 |
-3.11213144620648 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_468 |
WP_002218168 |
Q66AY1 |
pth |
196 aa |
aminoacyl-tRNA hydrolase |
1.0e-7 |
●●●●○ -3.11 |
-3.11236278736583 |
| Homo sapiens |
Haemophilus ducreyi 35000HP |
infected host |
Skin tissue |
6-8 days |
|
|
NP_115790 |
P58294 |
PROK1 |
105 aa |
prokineticin-1 precursor |
5.1e-6 |
●●●●○ -3.11 |
-3.11344923381668 |
| Homo sapiens |
Haemophilus ducreyi 35000HP |
infected host |
Skin tissue |
6-8 days |
|
|
NP_653297 |
Q5T1B0 |
AXDND1 |
1012 aa |
axonemal dynein light chain domain-containing protein 1 |
0.014 |
●●●●○ -3.11 |
-3.11349361233177 |
| Homo sapiens |
Mycobacterium tuberculosis variant bovis BCG str. ATCC 35733 |
infected host |
Human thp-1 cells |
24 h |
|
|
NP_079374 |
Q3SYC2 |
MOGAT2 |
334 aa |
2-acylglycerol O-acyltransferase 2 |
0.019 |
●●●●○ -3.11 |
-3.11383355405527 |
| Homo sapiens |
Haemophilus ducreyi 35000HP |
infected host |
Skin tissue |
6-8 days |
|
|
NP_001004459 |
Q8NGQ3 |
OR1S2 |
325 aa |
olfactory receptor 1S2 |
0.036 |
●●●●○ -3.12 |
-3.11563765440389 |
| Homo sapiens |
Haemophilus ducreyi 35000HP |
infected host |
Skin tissue |
6-8 days |
|
|
NP_079374 |
Q3SYC2 |
MOGAT2 |
334 aa |
2-acylglycerol O-acyltransferase 2 |
0.025 |
●●●●○ -3.12 |
-3.11570939241412 |
| Homo sapiens |
Salmonella enterica subsp. enterica serovar Typhimurium str. SL1344 |
infected host |
Hela-S3 cells |
24 h |
|
|
NP_443161 |
B1AJZ9 |
FHAD1 |
1412 aa |
forkhead-associated domain-containing protein 1 |
3.3e-5 |
●●●●○ -3.12 |
-3.11636927804391 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_2004 |
WP_024063089 |
|
|
387 aa |
putative lipopolysaccharide heptosyltransferase III |
2.9e-21 |
●●●●○ -3.12 |
-3.11672650035217 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
pathogen |
Lung tissue |
16 h |
Bacterial control measured at 37ºC |
HKX07_RS10885 |
WP_003114760 |
Q9I007 |
|
354 aa |
HlyD family secretion protein |
0.0098 |
●●●●○ -3.12 |
-3.11706199056902 |
| Homo sapiens |
Streptococcus pneumoniae D39 |
host |
Human type II lung epithelial cell line A549 |
30 min |
|
|
NP_000711 |
Q01668 |
CACNA1D |
2181 aa |
voltage-dependent L-type calcium channel subunit alpha-1D isoform a |
3.0e-22 |
●●●●○ -3.12 |
-3.11857260773634 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
infected host |
Lymphoid tissue |
3 days |
|
|
NP_001019396 |
Q5G865 |
Defa24 |
93 aa |
alpha-defensin 24 precursor |
2.7e-43 |
●●●●○ -3.12 |
-3.11886361551901 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_1596 |
WP_002208650 |
Q66DU2 |
cyoB |
663 aa |
cytochrome o ubiquinol oxidase subunit I |
4.8e-74 |
●●●●○ -3.12 |
-3.11952234868086 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_1597 |
WP_002208651 |
Q66DU3 |
cyoC |
204 aa |
cytochrome o ubiquinol oxidase subunit III |
7.4e-20 |
●●●●○ -3.12 |
-3.11999574532382 |
| Homo sapiens |
Haemophilus ducreyi 35000HP |
infected host |
Skin tissue |
6-8 days |
|
|
NP_001034219 |
O15296 |
ALOX15B |
647 aa |
arachidonate 15-lipoxygenase B isoform a |
0.0059 |
●●●●○ -3.12 |
-3.12044992832727 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
infected host |
Lung tissue |
16 h |
|
|
NP_001272741 |
Q9D0Z3 |
Tmem53 |
283 aa |
transmembrane protein 53 isoform a |
0.0044 |
●●●●○ -3.12 |
-3.12158179482858 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_4041 |
WP_002265141 |
|
|
712 aa |
phosphate acetyltransferase |
6.0e-55 |
●●●●○ -3.12 |
-3.12188975759791 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
infected host |
Lymphoid tissue |
3 days |
|
|
NP_705726 |
H7BWZ4 |
Clec2e |
216 aa |
C-type lectin domain family 2 member E |
5.4e-53 |
●●●●○ -3.12 |
-3.12214051188606 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_584 |
WP_011192340 |
Q66B87 |
|
284 aa |
hypothetical protein |
0.016 |
●●●●○ -3.12 |
-3.12340360577264 |
| Homo sapiens |
Salmonella enterica subsp. enterica serovar Typhimurium str. SL1344 |
pathogen |
Hela-S3 cells |
4 h |
Bacterial control measured at 37ºC |
SL1344_3869 |
WP_000024948 |
A0A0H3NUB6 |
ilvC |
491 aa |
ketol-acid reductoisomerase |
0.0066 |
●●●●○ -3.12 |
-3.12366193656498 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
infected host |
Lung tissue |
16 h |
|
|
NP_082611 |
Q640N4 |
Zfp248 |
576 aa |
zinc finger protein 248 isoform a |
3.5e-6 |
●●●●○ -3.12 |
-3.12462518109928 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
infected host |
Lung tissue |
16 h |
|
|
NP_001191986 |
A2BG90 |
Gm14295 |
64 aa |
predicted gene 14295 |
7.0e-5 |
●●●●○ -3.12 |
-3.12479307357649 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
infected host |
Lymphoid tissue |
3 days |
|
|
NP_001008419 |
Q5SGK3 |
Aox2 |
1345 aa |
aldehyde oxidase 2 |
0.002 |
●●●●○ -3.13 |
-3.12728658591609 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
pathogen |
Lung tissue |
16 h |
Bacterial control measured at 37ºC |
HKX07_RS22020 |
WP_003114981 |
Q9HW99 |
tadB |
294 aa |
type 4b pilus Flp biogenesis protein TadB |
4.5e-16 |
●●●●○ -3.13 |
-3.12763368527262 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
infected host |
Lymphoid tissue |
3 days |
|
|
NP_031647 |
P08074 |
Cbr2 |
244 aa |
carbonyl reductase [NADPH] 2 |
0.012 |
●●●●○ -3.13 |
-3.12819444883595 |
| Homo sapiens |
Haemophilus ducreyi 35000HP |
infected host |
Skin tissue |
6-8 days |
|
|
NP_001036170 |
Q1A5X6 |
IQCJ |
159 aa |
IQ domain-containing protein J isoform CaMBPv1 |
0.0049 |
●●●●○ -3.13 |
-3.12850173965736 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
infected host |
Lung tissue |
16 h |
|
|
NP_001334372 |
Q9DCT8 |
Crip2 |
84 aa |
cysteine-rich protein 2 isoform 2 |
0.0078 |
●●●●○ -3.13 |
-3.12948159840951 |
| Homo sapiens |
Haemophilus ducreyi 35000HP |
infected host |
Skin tissue |
6-8 days |
|
|
NP_570629 |
P42658 |
DPP6 |
865 aa |
dipeptidyl aminopeptidase-like protein 6 isoform 1 |
1.9e-8 |
●●●●○ -3.13 |
-3.13006379659602 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_2841 |
WP_011193233 |
Q664M4 |
|
232 aa |
phosphoglycolate phosphatase |
9.4e-10 |
●●●●○ -3.13 |
-3.13076492724962 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
infected host |
Lung tissue |
16 h |
|
|
NP_666343 |
Q91VL6 |
Zfp825 |
274 aa |
zinc finger protein 124 isoform 2 |
0.013 |
●●●●○ -3.14 |
-3.13629628859864 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
infected host |
Lung tissue |
16 h |
|
|
NP_032119 |
P97489 |
Gata5 |
404 aa |
transcription factor GATA-5 |
1.1e-6 |
●●●●○ -3.14 |
-3.13865129858116 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
infected host |
Lymphoid tissue |
3 days |
|
|
NP_663399 |
Q8K3M1 |
Rdh16f2 |
318 aa |
cis-retinol/3alpha hydroxysterol short-chain dehydrogenase-like precursor |
0.026 |
●●●●○ -3.14 |
-3.14200992323556 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_2942 |
WP_011193210 |
Q664W4 |
aceK |
575 aa |
bifunctional isocitrate dehydrogenase kinase/phosphatase |
8.5e-11 |
●●●●○ -3.14 |
-3.14221280930118 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_3867 |
WP_002208537 |
Q668H7 |
narP |
209 aa |
response regulator |
1.7e-7 |
●●●●○ -3.14 |
-3.14231106133997 |
| Homo sapiens |
Streptococcus pneumoniae D39 |
host |
Human type II lung epithelial cell line A549 |
30 min |
|
|
NP_001129663 |
Q63ZY3 |
KANK2 |
851 aa |
KN motif and ankyrin repeat domain-containing protein 2 isoform 2 |
9.1e-16 |
●●●●○ -3.14 |
-3.14482027118775 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
pathogen |
Lung tissue |
16 h |
Bacterial control measured at 37ºC |
HKX07_RS10380 |
WP_003114003 |
Q9HZR1 |
|
193 aa |
cytochrome b |
0.00018 |
●●●●○ -3.15 |
-3.14587547855105 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_3649 |
WP_002220062 |
Q667M0 |
|
188 aa |
D-glycero-beta-D-manno-heptose 1,7-bisphosphate 7-phosphatase |
1.3e-14 |
●●●●○ -3.15 |
-3.14636627093279 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_2629 |
WP_002228756 |
Q663S8 |
|
85 aa |
membrane protein insertion efficiency factor YidD |
7.2e-17 |
●●●●○ -3.15 |
-3.14687425997525 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
pathogen |
Lung tissue |
16 h |
Bacterial control measured at 37ºC |
HKX07_RS13130 |
WP_003113059 |
Q9I167 |
|
439 aa |
sorbosone dehydrogenase family protein |
3.4e-52 |
●●●●○ -3.15 |
-3.14772865295024 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_2158 |
WP_002209135 |
Q66FC9 |
frdC |
130 aa |
fumarate reductase subunit FrdC |
1.2e-8 |
●●●●○ -3.15 |
-3.14808131071601 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
infected host |
Lung tissue |
16 h |
|
|
XP_006531150 |
A6H603 |
Nwd1 |
1563 aa |
NACHT domain- and WD repeat-containing protein 1 isoform X2 |
2.2e-5 |
●●●●○ -3.15 |
-3.14923586582603 |
| Homo sapiens |
Streptococcus pneumoniae D39 |
pathogen |
Human type II lung epithelial cell line A549 |
30 min |
|
SPD_2068 |
WP_000681597 |
|
|
393 aa |
PDZ domain-containing protein |
0.00043 |
●●●●○ -3.15 |
-3.14931007268819 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_1821 |
WP_002209354 |
Q66EF9 |
dksA |
151 aa |
RNA polymerase-binding protein DksA |
4.1e-73 |
●●●●○ -3.15 |
-3.15144542150755 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_3826 |
WP_012104828 |
|
|
450 aa |
molecular chaperone |
8.5e-14 |
●●●●○ -3.15 |
-3.15158389695932 |
| Macaca fascicularis |
Streptococcus pyogenes |
infected host |
Skeletal muscle tissue |
24 h |
|
|
NP_001306322 |
E7EDU3 |
CRP |
|
|
0.0094 |
●●●●○ -3.15 |
-3.15200558032668 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_3004 |
WP_002210043 |
|
|
329 aa |
autoinducer 2 ABC transporter substrate-binding protein |
1.7e-13 |
●●●●○ -3.15 |
-3.15354544374808 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_1849 |
WP_011191740 |
Q66EI7 |
hofB |
512 aa |
type II secretion system protein GspE |
9.0e-9 |
●●●●○ -3.15 |
-3.15365927356699 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
infected host |
Lung tissue |
16 h |
|
|
NP_032031 |
O89101 |
Fgf18 |
207 aa |
fibroblast growth factor 18 precursor |
2.7e-5 |
●●●●○ -3.15 |
-3.15489476312312 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_1775 |
WP_002209404 |
Q66EB2 |
|
256 aa |
D-threitol dehydrogenase |
1.8e-7 |
●●●●○ -3.16 |
-3.15604105655019 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
infected host |
Lymphoid tissue |
3 days |
|
|
NP_031928 |
P22389 |
Edn2 |
175 aa |
endothelin-2 preproprotein |
0.0033 |
●●●●○ -3.16 |
-3.15870676391527 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
infected host |
Lymphoid tissue |
3 days |
|
|
NP_001157228 |
Q8BK48 |
Ces2e |
559 aa |
pyrethroid hydrolase Ces2e precursor |
1.8e-60 |
●●●●○ -3.16 |
-3.16035030483848 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
pathogen |
Lung tissue |
16 h |
Bacterial control measured at 37ºC |
HKX07_RS12330 |
WP_003120049 |
Q9I0R6 |
|
113 aa |
hypothetical protein |
6.3e-15 |
●●●●○ -3.16 |
-3.16306176373205 |
| Homo sapiens |
Salmonella enterica subsp. enterica serovar Typhimurium str. SL1344 |
infected host |
Monocytic infected cells |
24 h |
|
|
NP_001276011 |
Q8TDQ1 |
CD300LF |
194 aa |
CMRF35-like molecule 1 isoform 2 |
3.5e-5 |
●●●●○ -3.16 |
-3.16312609217375 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_2908 |
WP_002213341 |
Q664U0 |
rplO |
144 aa |
50S ribosomal protein L15 |
9.0e-29 |
●●●●○ -3.17 |
-3.16948507385378 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
infected host |
Lung tissue |
16 h |
|
|
NP_001307229 |
Q8CGV8 |
Mmp28 |
520 aa |
matrix metalloproteinase-28 isoform 3 precursor |
1.7e-15 |
●●●●○ -3.17 |
-3.16992211582486 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
pathogen |
Lung tissue |
16 h |
Bacterial control measured at 37ºC |
HKX07_RS01110 |
WP_003112671 |
Q9I6S3 |
|
134 aa |
malonate transporter subunit MadL |
3.0e-15 |
●●●●○ -3.17 |
-3.17063482364298 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
infected host |
Lymphoid tissue |
3 days |
|
|
NP_032512 |
P97449 |
Anpep |
966 aa |
aminopeptidase N |
1.6e-73 |
●●●●○ -3.17 |
-3.17335507453335 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
infected host |
Lymphoid tissue |
3 days |
|
|
NP_001192178 |
Q6XQH0 |
Gal3st2 |
394 aa |
galactose-3-O-sulfotransferase 2 |
6.6e-5 |
●●●●○ -3.17 |
-3.17338784531292 |
| Homo sapiens |
Mycobacterium tuberculosis variant bovis BCG str. ATCC 35733 |
infected host |
Human thp-1 cells |
24 h |
|
|
NP_036536 |
O95626 |
ANP32D |
131 aa |
acidic leucine-rich nuclear phosphoprotein 32 family member D |
0.00015 |
●●●●○ -3.17 |
-3.17400163932947 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_1521 |
WP_002208576 |
Q66DL9 |
|
304 aa |
SPFH/Band 7/PHB domain protein |
9.8e-12 |
●●●●○ -3.17 |
-3.17411748910481 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
infected host |
Lung tissue |
16 h |
|
|
NP_001093106 |
G3X9N3 |
Pnmal2 |
661 aa |
paraneoplastic antigen-like protein 8B |
0.00015 |
●●●●○ -3.17 |
-3.17449891586343 |
| Homo sapiens |
Haemophilus ducreyi 35000HP |
infected host |
Skin tissue |
6-8 days |
|
|
NP_001309808 |
Q96LD1 |
SGCZ |
278 aa |
zeta-sarcoglycan isoform 2 |
3.2e-5 |
●●●●○ -3.18 |
-3.17510377694374 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
infected host |
Lymphoid tissue |
3 days |
|
|
NP_001161395 |
A6H584 |
Col6a5 |
2640 aa |
collagen alpha-5(VI) chain precursor |
5.4e-101 |
●●●●○ -3.18 |
-3.17514349523686 |
| Homo sapiens |
Haemophilus ducreyi 35000HP |
infected host |
Skin tissue |
6-8 days |
|
|
NP_001166282 |
Q8IWU4 |
SLC30A8 |
320 aa |
zinc transporter 8 isoform b |
6.7e-5 |
●●●●○ -3.18 |
-3.17646266343966 |
| Homo sapiens |
Salmonella enterica subsp. enterica serovar Typhimurium str. SL1344 |
pathogen |
Hela-S3 cells |
4 h |
Bacterial control measured at 37ºC |
SL1344_1887 |
WP_000659236 |
A0A0H3NCT3 |
fliB |
401 aa |
lysine-N-methylase |
0.0055 |
●●●●○ -3.18 |
-3.17685291590646 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_2003 |
WP_011191668 |
Q66EY5 |
|
408 aa |
O-antigen ligase family protein |
5.4e-20 |
●●●●○ -3.18 |
-3.17704088069514 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_919 |
WP_011192135 |
|
|
308 aa |
hypothetical protein |
0.016 |
●●●●○ -3.18 |
-3.17740373739986 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
infected host |
Lymphoid tissue |
3 days |
|
|
NP_112474 |
P14246 |
Slc2a2 |
523 aa |
solute carrier family 2, facilitated glucose transporter member 2 |
7.7e-35 |
●●●●○ -3.18 |
-3.17810681860858 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
infected host |
Lung tissue |
16 h |
|
|
NP_001036225 |
Q78KK3 |
Slc22a18 |
410 aa |
solute carrier family 22 member 18 |
0.0035 |
●●●●○ -3.18 |
-3.17864696566335 |
| Homo sapiens |
Streptococcus pneumoniae D39 |
pathogen |
Human type II lung epithelial cell line A549 |
30 min |
|
SPD_0936 |
WP_000261798 |
A0A0H2ZNS5 |
|
205 aa |
relaxase/mobilization nuclease domain-containing protein |
8.9e-9 |
●●●●○ -3.18 |
-3.17937852886916 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
pathogen |
Lung tissue |
16 h |
Bacterial control measured at 37ºC |
HKX07_RS04450 |
WP_010895669 |
Q9HWU4 |
cupB3 |
844 aa |
fimbrial biogenesis outer membrane usher protein |
2.8e-20 |
●●●●○ -3.18 |
-3.17938125966652 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_830 |
WP_002211110 |
Q66BU5 |
flgB |
137 aa |
flagellar basal body rod protein FlgB |
0.026 |
●●●●○ -3.18 |
-3.18082507964563 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
infected host |
Lung tissue |
16 h |
|
|
NP_076045 |
Q9R008 |
Mvk |
395 aa |
mevalonate kinase isoform 2 |
2.2e-10 |
●●●●○ -3.18 |
-3.18120801529498 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_280 |
WP_011192471 |
Q66AE8 |
|
309 aa |
hypothetical protein |
4.6e-7 |
●●●●○ -3.18 |
-3.18154559889969 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
pathogen |
Lung tissue |
16 h |
Bacterial control measured at 37ºC |
HKX07_RS15895 |
WP_003113619 |
Q9I2M4 |
|
340 aa |
transporter |
1.9e-22 |
●●●●○ -3.18 |
-3.18168329775878 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_3936 |
WP_011192730 |
Q668N6 |
|
158 aa |
multidrug/biocide efflux PACE transporter |
0.0076 |
●●●●○ -3.18 |
-3.18237636753437 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
infected host |
Lymphoid tissue |
3 days |
|
|
NP_666229 |
Q91W20 |
Lrrc26 |
331 aa |
leucine-rich repeat-containing protein 26 precursor |
8.5e-21 |
●●●●○ -3.18 |
-3.18248625192808 |
| Homo sapiens |
Haemophilus ducreyi 35000HP |
infected host |
Skin tissue |
6-8 days |
|
|
NP_938167 |
Q6ZWB6 |
KCTD8 |
473 aa |
BTB/POZ domain-containing protein KCTD8 |
1.3e-6 |
●●●●○ -3.18 |
-3.18434570392607 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_RS22970 |
WP_002231833 |
|
|
207 aa |
membrane protein |
4.9e-5 |
●●●●○ -3.18 |
-3.18455574189461 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
pathogen |
Lung tissue |
16 h |
Bacterial control measured at 37ºC |
HKX07_RS13120 |
WP_010895614 |
Q9I165 |
treA |
545 aa |
alpha,alpha-trehalase TreA |
6.8e-40 |
●●●●○ -3.19 |
-3.18541961897258 |
| Homo sapiens |
Haemophilus ducreyi 35000HP |
infected host |
Skin tissue |
6-8 days |
|
|
NP_002398 |
O75556 |
SCGB2A1 |
95 aa |
mammaglobin-B precursor |
0.015 |
●●●●○ -3.19 |
-3.18798839220215 |
| Mus musculus |
Pseudomona aeruginosa PA01 |
pathogen |
Lung tissue |
16 h |
Bacterial control measured at 37ºC |
HKX07_RS01400 |
WP_003112930 |
Q9I6L6 |
|
256 aa |
hypothetical protein |
1.1e-7 |
●●●●○ -3.19 |
-3.18831959681604 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_1249 |
WP_002208858 |
|
|
205 aa |
ATP-binding protein |
0.024 |
●●●●○ -3.19 |
-3.18997894131661 |
| Homo sapiens |
Mycobacterium tuberculosis variant bovis BCG str. ATCC 35733 |
infected host |
Human thp-1 cells |
24 h |
|
|
NP_001513 |
P51841 |
GUCY2F |
1108 aa |
retinal guanylyl cyclase 2 |
6.8e-10 |
●●●●○ -3.19 |
-3.19003106570996 |
| Mus musculus |
Yersinia pseudotuberculosis IP 32953 |
pathogen |
Lymphoid tissue |
3 days |
Bacterial control measured at mid-exponential growth phase at 25ºC |
BZ17_136 |
WP_002211813 |
Q66A14 |
ppsA |
794 aa |
phosphoenolpyruvate synthase |
1.5e-23 |
●●●●○ -3.19 |
-3.19221425089477 |